Olav Dalgard
Universitetet i Oslo
H-index: 41
Europe-Norway
Top articles of Olav Dalgard
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs | International Journal of Drug Policy | Eirik Opheim Olav Dalgard Kjersti Ulstein Hanne Sørli Øystein Backe | 2024/1/1 |
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial | Journal of Infection | Maya Hites Eva Larranaga Lapique Clément R Massonnaud Drifa Belhadi Simon Jamard | 2024/3/1 |
Identification of a newly emerging second-generation HIV-1 circulating recombinant form (CRF145_0755) among men who have sex with men in China | Journal of Infection | Yanling Ma Huichao Chen Jie Dai Lijuan Dong Manhong Jia | 2024/3/1 |
Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli | Infectious Diseases | Nina Handal Jimmy Whitworth Magnus Nakrem Lyngbakken Jan Erik Berdal Olav Dalgard | 2024/1/2 |
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions | Alison D Marshall Alex R Willing Abe Kairouz Evan B Cunningham Alice Wheeler | 2024/2/14 | |
Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): a stepped wedge cluster randomized trial | Clinical Infectious Diseases | Håvard Midgard Kristian Braathen Malme Charlotte Meinich Pihl Riikka Mari Berg-Pedersen Lars Tanum | 2024/3/15 |
Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study | Substance Abuse Treatment, Prevention, and Policy | Karl Trygve Druckrey-Fiskaaen Jørn Henrik Vold Tesfaye Madebo Håvard Midgard Olav Dalgard | 2024/3/26 |
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials | Nature communications | Cathrine Axfors Andreas M Schmitt Perrine Janiaud Janneke van’t Hooft Sherief Abd-Elsalam | 2024/2/5 |
Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations | Journal of addictive diseases | Fatemeh Chalabianloo Gudrun Høiseth Jørn Henrik Vold Kjell Arne Johansson Marianne K Kringen | 2023/1/2 |
Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral | International Journal of Drug Policy | Jason Grebely Geert Robaeys Philip Bruggmann Alessio Aghemo Markus Backmund | 2023/1/1 |
The Nuc-Stop study: An open-label, randomized trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B patients | J. Hepatol | Asgeir Johannessen Dag Henrik Reikvam Soo Aleman Nega Berhe Nina Weis | 2023/6/1 |
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study | The Lancet Gastroenterology & Hepatology | Devin Razavi-Shearer Ivane Gamkrelidze Calvin Pan Jidong Jia Thomas Berg | 2023/10/1 |
Statusrapport om eliminasjon av hepatitt B og C som folkehelseproblem i Norge | Hilde Kløvstad Martin Ingvald Blindheim Kristin Helene Skullerud Olav Dalgard Håvard Midgard | 2023 | |
Corrigendum to ‘EASL recommendations on treatment of hepatitis C: Final update of the series’[J Hepatol 73 (2020) 1170–1218] | Journal of Hepatology | European Association For The Study Of The Liver | 2023/2/1 |
Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection | International Journal of Drug Policy | Jason Grebely Geert Robaeys Philip Bruggmann Alessio Aghemo Markus Backmund | 2023/1/1 |
Recommendations for the management of hepatitis C virus infection in injection drug users | International Journal Of Drug Policy | Jason Grebely Geert Robaeys Philip Bruggmann Alessio Aghemo Markus Backmund | 2023/1/1 |
Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study | Liver International | Oluwaseun Falade‐Nwulia Rachel E Gicquelais Jacquie Astemborski Sean D McCormick Greg Kirk | 2020/10 |
Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection | Journal of addictive diseases | Olav Dalgard Alain H Litwin Oren Shibolet Jason Grebely Ronald Nahass | 2023/7/3 |
Treatment cessation in HBeAg-negative chronic hepatitis B: clinical response is associated with increase in specific proinflammatory cytokines | Scientific Reports | Marte Holmberg Hans Christian D Aass Olav Dalgard Ellen Samuelsen Dan Sun | 2023/12/18 |
Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden | International Journal of Drug Policy | Jason Grebely Geert Robaeys Philip Bruggmann Alessio Aghemo Markus Backmund | 2023/1/1 |
